Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan

被引：3

作者：

Hsieh, Meng-Hsuan ^{[1
,2
,3
,4
,5
,6
,7
,8
]}

Bair, Ming-Jong ^{[14
]}

Tsai, Pei-Chien ^{[2
,3
]}

Tseng, Kuo-Chih ^{[32
]}

Lo, Ching-Chu ^{[19
]}

Chen, Chi-Yi ^{[20
]}

Kuo, Hsing-Tao ^{[23
]}

Hung, Chao-Hung ^{[9
,10
]}

Lai, Hsueh-Chou ^{[18
]}

Peng, Cheng-Yuan ^{[18
]}

Wang, Jing-Houng ^{[21
]}

Chen, Jyh-Jou ^{[33
]}

Lee, Pei-Lun ^{[33
]}

Chien, Rong-Nan ^{[24
]}

Yang, Chi-Chieh ^{[16
]}

Lo, Gin-Ho ^{[11
,12
]}

Kao, Jia-Horng ^{[25
,26
]}

Liu, Chun-Jen ^{[25
,26
]}

Liu, Chen-Hua ^{[25
,26
]}

Yan, Sheng-Lei ^{[17
]}

Lin, Chun-Yen ^{[24
]}

Su, Wei-Wen ^{[15
]}

Chu, Cheng-Hsin ^{[27
]}

Chen, Chih-Jen ^{[27
]}

Tung, Shui-Yi ^{[9
,10
]}

Tai, Chi-Ming ^{[11
,12
]}

Lin, Chih-Wen ^{[11
,12
]}

Cheng, Pin-Nan ^{[22
]}

Chiu, Yen-Cheng ^{[22
]}

Wang, Chia-Chi ^{[30
,31
]}

Cheng, Jin-Shiung ^{[13
]}

Tsai, Wei-Lun ^{[13
]}

Lin, Han-Chieh ^{[28
]}

Huang, Yi-Hsiang ^{[28
,29
]}

Yeh, Ming-Lun ^{[2
,3
,4
,5
,6
,7
]}

Huang, Chung-Feng ^{[2
,3
,4
,5
,6
,7
]}

Huang, Jee-Fu ^{[2
,3
,4
,5
,6
,7
]}

Dai, Chia-Yen ^{[2
,3
,4
,5
,6
,7
]}

Yu, Ming-Lung ^{[2
,3
,4
,5
,6
,7
]}

Chuang, Wan-Long ^{[2
,3
,4
,5
,6
,7
]}

机构：

[1] Kaohsiung Med Univ Hosp, Hlth Management Ctr, Dept Occupat & Environm Med, Kaohsiung, Taiwan

[2] Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan

[3] Kaohsiung Med Univ Hosp, Hepatitis Ctr, Kaohsiung, Taiwan

[4] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan

[5] Kaohsiung Med Univ, Hepatitis Res Ctr, Coll Med, Kaohsiung, Taiwan

[6] Kaohsiung Med Univ, Ctr Canc Res, Kaohsiung, Taiwan

[7] Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res, Kaohsiung, Taiwan

[8] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan

[9] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan

[10] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan

[11] I Shou Univ, E Da Hosp, Dept Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan

[12] I Shou Univ, Sch Med, Coll Med, Kaohsiung, Taiwan

[13] Kaohsiung Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Kaohsiung, Taiwan

[14] Taitung Mackay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taitung, Taiwan

[15] Changhua Christian Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[16] Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[17] Chang Bing Show Chwan Mem Hosp, Div Gastroenterol, Dept Internal Med, Changhua, Taiwan

[18] China Med Univ Hosp, Div Hepatogastroenterol, Dept Internal Med, Taichung, Taiwan

[19] St Martin Porres Hosp Daya, Dept Internal Med, Daya, Taiwan

[20] Chiayi Christian Hosp, Dept Internal Med, Chiayi, Taiwan

[21] ChiaYi Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Chiayi, Taiwan

[22] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Div Gastroenterol & Hepatol, Dept Internal Med,Coll Med, Tainan, Taiwan

[23] Chi Mei Med Ctr, Div Hepatogastroenterol, Dept Internal Med, Tainan, Taiwan

[24] Chang Gung Mem Hosp, Div Hepatol, Dept Gastroenterol & Hepatol, Linkou Med Ctr, Keelung, Taiwan

[25] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan

[26] Natl Taiwan Univ Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan

[27] MacKay Mem Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan

[28] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan

[29] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan

[30] Buddhist Tzuchi Med Fdn, Div Gastroenterol, Taipei Tzuchi Hosp, Dept Internal Med, New Taipei, Taiwan

[31] Tzu Chi Univ, Sch Med, Hualien, Taiwan

[32] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Gastroenterol, Chiayi, Taiwan

[33] Chi Mei Med Ctr, Div Gastroenterol & Hepatol, Tainan, Taiwan

来源：

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2021年 / 36卷 / 08期

关键词：

chronic kidney disease; end‐ stage renal disease; hepatitis C virus; interferon; VIRUS-INFECTION; GLUCOSE ABNORMALITIES; VIRAL-HEPATITIS; FIBROSIS; OUTCOMES; ASSOCIATION; NATIONWIDE; GENOTYPE; COHORT; AREA;

D O I：

10.1111/jgh.15469

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Background and Aim Chronic hepatitis C virus (HCV) infection is associated with impaired renal function. The aim of this study is to explore the risk of and factors associated with end-stage renal diseases (ESRD) under maintenance dialysis among HCV patients after anti-HCV therapy. Methods A total of 12 696 HCV-infected patients with interferon-based therapy, including 9679 (76.2%) achieving sustained virological response (SVR), were enrolled from 23 hospitals in Taiwan. Results During a mean follow-up period of 5.3 years (67 554 person-years), the annual incidence of 4.1/10 000 person-years, 4.0/10 000 and 4.7/10 000 person-years among SVR patients and non-SVR patients, respectively. History of diabetes and baseline estimated glomerular filtration rate < 60 mL/min/m(2), instead of SVR, were the significant risk factors for developing ESRD with maintenance dialysis after anti-HCV therapy (adjusted hazard ratio 7.75 and 9.78). Conclusion Diabetes and baseline impaired renal function were strongly associated with progression to ESRD with maintenance dialysis among chronic HCV-infected patients after antiviral therapy.

引用

页码：2247 / 2254

页数：8

共 50 条

[41] Waitlist Time, Age, and Social Vulnerability: Impact on the Survival Benefit of Deceased Donor Kidney Transplantation Versus Long-term Dialysis Among Patients With End-stage Renal Disease
Yang, Jason
Endo, Yutaka
Munir, Muhammad Musaab
Woldesenbet, Selamawit
Altaf, Abdulla
Limkemann, Ashley
Schenk, Austin
Washburn, Kenneth
Pawlik, Timothy M.
TRANSPLANTATION, 2025, 109 (01) : e64 - e74
[42] Long-term outcome with end-stage renal disease - survival is not enough: does dialysis or kidney transplantation matter?
Schulz, K. -H.
Thaiss, F.
BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2012, 55 (04) : 543 - 551
[43] Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment
Yu, Ming-Lung
Huang, Chung-Feng
Yeh, Ming-Lun
Tsai, Pei-Chien
Huang, Ching-I.
Hsieh, Meng-Hsuan
Hsieh, Ming-Yen
Lin, Zu-Yau
Chen, Shinn-Cherng
Huang, Jee-Fu
Dai, Chia-Yen
Chuang, Wan-Long
CLINICAL CANCER RESEARCH, 2017, 23 (07) : 1690 - 1697
[44] A Comprehensive Long-Term Prognosis of Chronic Hepatitis C Patients With Antiviral Therapy: A Meta-Analysis of Studies From 2008 to 2014
Wen, Ya
Zheng, Yi Xiang
Tan, De Ming
HEPATITIS MONTHLY, 2015, 15 (05)
[45] Serum albumin and hospitalization among pediatric patients with end-stage renal disease who started dialysis therapy
Okuda, Yusuke
Obi, Yoshitsugu
Streja, Elani
Laster, Marciana
Rhee, Connie
Langman, Craig B.
Jernigan, Stephanie M.
Salusky, Isidro B.
Tentori, Francesca
Schreiber, Martin J.
Brunelli, Steven M.
Kalantar-Zadeh, Kamyar
PEDIATRIC NEPHROLOGY, 2019, 34 (10) : 1799 - 1809
[46] Long-term incense use and the risk of end-stage renal disease among Chinese in Singapore: the Singapore Chinese health study
Geng, Ting-Ting
Jafar, Tazeen Hasan
Yuan, Jian-Min
Koh, Woon-Puay
BMC NEPHROLOGY, 2019, 20 (1)
[47] Increased risk of dialysis and end-stage renal disease among HIV patients in Denmark compared with the background population
Rasch, Magnus G.
Helleberg, Marie
Feldt-Rasmussen, Bo
Kronborg, Gitte
Larsen, Carsten S.
Pedersen, Court
Pedersen, Gitte
Gerstoft, Jan
Obel, Niels
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (06) : 1232 - 1238
[48] Long-Term Outcomes of Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease
Ogami, Takuya
Kurlansky, Paul
Takayama, Hiroo
Ning, Yuming
Ali, Ziad A.
Nazif, Tamim M.
Vahl, Torsten P.
Khalique, Omar
Patel, Amisha
Hamid, Nadira
Ng, Vivian G.
Hahn, Rebecca T.
Avgerinos, Dimitrios V.
Leon, Martin B.
Kodali, Susheel K.
George, Isaac
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (16):
[49] Long-Term Outcomes of Patients with Liver Cirrhosis After Eradication of Chronic Hepatitis C with Direct-Acting Antiviral Drugs (DAAs)
Salama, Mohsen
Darwesh, Nehad
Elsabaawy, Maha Mohammad
Abdelsameea, Eman
Gomaa, Asmaa
Sabry, Aliaa
JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 2115 - 2132
[50] Thyroid Dysfunction and Long-term Outcome during and after Interferon-alpha Therapy in Patients with Chronic Hepatitis C
Themistoklis, Vasiliadis
Panagiotis, Anagnostis
Georgios, Nalmpantidis
Konstantinos, Soufleris
Kaliopi, Patsiaoura
Nikolaos, Grammatikos
Eleni, Orfanou-Koumerkeridou
Konstantinos, Kargiotis
Aristidis, Slavakis
Aristidis, Deliyiannidis
Nikolaos, Eugenidis
ANNALS ACADEMY OF MEDICINE SINGAPORE, 2011, 40 (09) : 394 - 400

← 1 2 3 4 5 →